Skip to main content

MoneyWorks4Me

Granules India board to consider un-audited financial results

01 Feb 2018 Evaluate

Granules India has informed that a meeting of the Board of Directors of the Company is scheduled to be held on February 08, 2018, to consider and approve the Un-audited Financial Results for the third quarter ended December 31, 2017 and the payment of third interim dividend for the FY 2017-18, if any. Further, Insider Trading Window of the company is closed from January 31, 2018 to February 10, 2018 in view of the above mentioned Board Meeting.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..